Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Maravai LifeSciences Inc...

    NASDAQ: MRVI · Real-Time Price · USD
    2.15
    0.02 (0.94%)
    At close: Jun 16, 2025, 3:59 PM
    2.17
    0.69%
    After-hours: Jun 16, 2025, 06:51 PM EDT

    Maravai LifeSciences Statistics

    Share Statistics

    Maravai LifeSciences has 143.97M shares outstanding. The number of shares has increased by 8.15% in one year.

    Shares Outstanding

    n/a
    		 143.97M

    Shares Change (YoY)

    n/a
    		 8.15%

    Shares Change (QoQ)

    n/a
    		 1.27%

    Owned by Institutions (%)

    n/a
    		 99.14%

    Shares Floating

    n/a
    		 107.06M

    Failed to Deliver (FTD) Shares

    n/a
    		 7,708

    FTD / Avg. Volume

    n/a
    		 0.32%

    Short Selling Information

    The latest short interest is 13.67M, so 9.5% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 13.67M

    Short % of Shares Out

    n/a
    		 9.5%

    Short % of Float

    n/a
    		 11.29%

    Short Ratio (days to cover)

    n/a
    		 7.69

    Valuation Ratios

    The PE ratio is -5.19 and the forward PE ratio is -9.3. Maravai LifeSciences's PEG ratio is -0.31.

    PE Ratio

    n/a
    		 -5.19

    Forward PE

    n/a
    		 -9.3

    PS Ratio

    n/a
    		 2.9

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 2.31

    P/FCF Ratio

    n/a
    		 -33.87

    PEG Ratio

    n/a
    		 -0.31
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Maravai LifeSciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.53, with a Debt / Equity ratio of 1.16.

    Current Ratio

    n/a
    		 7.53

    Quick Ratio

    n/a
    		 6.65

    Debt / Equity

    n/a
    		 1.16

    Debt / EBITDA

    n/a
    		 -2.4

    Debt / FCF

    n/a
    		 -16.97

    Interest Coverage

    n/a
    		 -4.94

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $454,710.53

    Profits Per Employee

    n/a
    		 $-254,115.79

    Employee Count

    n/a
    		 570

    Asset Turnover

    n/a
    		 0.26

    Inventory Turnover

    n/a
    		 3.01

    Taxes

    Income Tax

    n/a
    		 -1.86M

    Effective Tax Rate

    n/a
    		 0.71%

    Stock Price Statistics

    The stock price has increased by -70.22% in the last 52 weeks. The beta is 0.25, so Maravai LifeSciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.25

    52-Week Price Change

    n/a
    		 -70.22%

    50-Day Moving Average

    n/a
    		 2.08

    200-Day Moving Average

    n/a
    		 4.8

    Relative Strength Index (RSI)

    n/a
    		 48.37

    Average Volume (20 Days)

    n/a
    		 2,376,842

    Income Statement

    In the last 12 months, Maravai LifeSciences had revenue of 259.19M and earned -144.85M in profits. Earnings per share was -1.05.

    Revenue

    n/a
    		 259.19M

    Gross Profit

    n/a
    		 108.31M

    Operating Income

    n/a
    		 -235.62M

    Net Income

    n/a
    		 -144.85M

    EBITDA

    n/a
    		 -156.92M

    EBIT

    n/a
    		 -213.78M

    Earnings Per Share (EPS)

    n/a
    		 -1.05
    Full Income Statement

    Balance Sheet

    The company has 322.4M in cash and 376.69M in debt, giving a net cash position of -54.29M.

    Cash & Cash Equivalents

    n/a
    		 322.4M

    Total Debt

    n/a
    		 376.69M

    Net Cash

    n/a
    		 -54.29M

    Retained Earnings

    n/a
    		 140.89M

    Total Assets

    n/a
    		 959.75M

    Working Capital

    n/a
    		 313.12M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 7.46M and capital expenditures -29.66M, giving a free cash flow of -22.19M.

    Operating Cash Flow

    n/a
    		 7.46M

    Capital Expenditures

    n/a
    		 -29.66M

    Free Cash Flow

    n/a
    		 -22.19M

    FCF Per Share

    n/a
    		 -0.16
    Full Cash Flow Statement

    Margins

    Gross margin is 41.79%, with operating and profit margins of -90.91% and -55.89%.

    Gross Margin

    n/a
    		 41.79%

    Operating Margin

    n/a
    		 -90.91%

    Pretax Margin

    n/a
    		 -100.89%

    Profit Margin

    n/a
    		 -55.89%

    EBITDA Margin

    n/a
    		 -60.54%

    EBIT Margin

    n/a
    		 -90.91%

    FCF Margin

    n/a
    		 -8.56%

    Dividends & Yields

    MRVI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MRVI is $6.5, which is 202.3% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $6.5

    Price Target Difference

    n/a
    		 202.3%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 10
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.41

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist